(ON-DEMAND ACOI 2025) Today's Heart Failure Landscape: Reviewing Traditional Approaches, SGLT2 Inhibitors, and Device News
-
Register
- Non-member - $45
- Member - $35
- Resident/Fellow - $10
- Student - Free!
CME Credit Available:
This activity offers 1 1A AOA
Note: ACOI reports credits to the AOA at the beginning of each month.
Learning Objectives:
In this session, you'll learn how to:
- Upon completion, participant will be able to define the trajectory-based approach to left ventricular ejection fraction (LVEF) analysis and its impact on decision-making in HFrEF care.
- Upon completion, participant will be able to describe barriers and facilitators to the implementation of quadruple guideline-directed medical therapy in patients with HFrEF.
- Upon completion, participant will be able to describe how to use digital health tools effectively to monitor patient status and optimize therapy adherence in heart failure management.
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Arash Karnama, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
Release & Review Date:
This activity is valid from January 1, 2026, until January 1, 2029.
Arash Karnama, DO, FACOI
Clinical Associate Professor of Medicine
Oklahoma State University
Arash Karnama, DO is a clinical associate professor of medicine at Oklahoma State University Center for Health Sciences. He is a board certified interventional cardiologist. He received his Doctor of Osteopathic Medicine degree from Des Moines University. He completed his residency in internal medicine at Penn State Milton S. Hershey Medical Center. He completed his fellowship in cardiology and interventional cardiology at Oklahoma State University.
The faculty member, for this activity, has no relevant relationships with ineligible companies to disclose.